news

« BACK

Health



Results 1 - 20 of 186.
1 2 3 4 5 10 Next »


Life Sciences - Health - 19.04.2024
Scientists analyse the potential of erythropoietin (EPO) as a treatment for neurological and psychiatric diseases
Scientists analyse the potential of erythropoietin (EPO) as a treatment for neurological and psychiatric diseases
Researchers from eleven centres in Spain, the United States and Germany, including the University of Valencia (UV), INCLIVA and Carlos III Health Institute, have analysed the effect on the human brain of erythropoietin (EPO), a hormone secreted mainly by the kidneys, as well as its potential as therapy for the treatment of neurological and psychiatric diseases.

Health - 27.03.2024
Dual effect of epicardial fat in patients with acute myocardial infarction
Dual effect of epicardial fat in patients with acute myocardial infarction
A study shows the dual effect of epicardial fat in patients with acute myocardial infarction Researchers from several institutions, including the University of Valencia and the INCLIVA Health Research Institute, of the University Clinical Hospital of Valencia, have developed a study to evaluate the correlation between epicardial adipose tissue (the layer of fat covering the heart), with infarct size and reduction in cardiac function in the short (1 week) and long term (6 months) in acute myocardial infarction (AMI).

Health - Computer Science - 21.03.2024
VIPERA, a software that evaluates how SARS-CoV-2 evolves throughout the infection
VIPERA, a software that evaluates how SARS-CoV-2 evolves throughout the infection
Researchers create VIPERA, a software that evaluates how SARS-CoV-2 evolves throughout the infection A research team from the Institute of Integrative Systems Biology (I2SysBio, a joint centre of the University of Valencia and the Spanish National Research Council) and other Spanish centres has created software that allows analysing the SARS-CoV-2 evolution within patients who suffer chronic infections from this virus, which can last many months.

Health - Mathematics - 20.03.2024
A computational model has been created to simulate the biomechanical growth of breast tumors
A computational model has been created to simulate the biomechanical growth of breast tumors
Research by UC3M and Johns Hopkins University Scientists from Universidad Carlos III de Madrid (UC3M) and Johns Hopkins University (JHU), in the USA, have analyzed the growth of breast tumors from a biomechanical perspective and have created a computational model that simulates the invasion process of cancer cells, depending on the characteristics of the surrounding tissue and cell junctions, among other parameters.

Pharmacology - Health - 12.03.2024
The UV spin-off company ARTHEx Biotech develops a pharmaceutical drug for Myotonic Dystrophy type 1
The pharmaceutical drug, named ATX-01, has just been authorised to start clinical trials in the US. This new therapeutic advance gives hope to those suffering from Myotonic Dystrophy type 1, an hereditary degenerative disease currently lacking of effective treatment.

Life Sciences - Health - 29.02.2024
An important migratory route of young neurons in the brains of newborns has been discovered
An important migratory route of young neurons in the brains of newborns has been discovered
A study published in Nature, with notable participation from the University of Valencia, has identified a new migratory route of young neurons in the human infant brain. This migratory pathway extends from the lateral ventricle, where these cells are born, to the entorhinal cortex, an area interconnected with the regions where memory and learning are consolidated.

Life Sciences - Health - 30.01.2024
New mechanism to control cell division
New mechanism to control cell division
Research from the University of Valencia describes a new mechanism to control cell division The Cell Cycle Regulation in Eukaryotes research group at the University of Valencia (UV) has discovered a new way to control cell division, a key process to understand diseases such as cancer, in which cell proliferation loses the correct operation of its control and braking mechanisms.

Health - 24.01.2024
Veterinary researchers develop new method to combat malaria
Veterinary researchers develop new method to combat malaria
Malaria continues to infect more than 200 million people a year, of which a part of them, mostly children, die from the disease. Over the years, methods have been developed against this disease, from simple but efficient mosquito nets to promising vaccines, however, a definitive solution has not yet been found, so research is still necessary.

Health - Life Sciences - 24.01.2024
Bacteria in the syphilis family were present in America at least a thousand years before the arrival of Christopher Columbus
Bacteria in the syphilis family were present in America at least a thousand years before the arrival of Christopher Columbus
A new study reveals that bacteria in the syphilis family were present in America at least a thousand years before the arrival of Christopher Columbus One of the greatest mysteries in the history of epidemics is whether or not syphilis was introduced into Europe after Columbus- first voyage to the Americas.

Media - Health - 18.01.2024
Young Spaniards trust science less than older people
Research by the Universidad Carlos III de Madrid (UC3M) and the University of Santiago de Compostela (USC) that analyses how Spaniards kept themselves informed during the COVID-19 pandemic and their

Health - Life Sciences - 17.01.2024
Microbe discovered which prevents mosquitoes from harbouring malaria parasite
Microbe discovered which prevents mosquitoes from harbouring malaria parasite
Scientific research, in which a researcher from the Universidad Carlos III de Madrid (UC3M) has participated, has identified a bacteria that prevents the malaria parasite from completing its cycle inside mosquitoes. This advance, recently published in the journal Science, could provide an additional weapon against the spread of malaria in the world.

Health - Agronomy / Food Science - 15.01.2024
Atlantic diet: key to lower mortality in Europe
Atlantic diet: key to lower mortality in Europe
Researchers from the Autonomous University of Madrid (UAM), CIBERESP and IMDEA Alimentación have associated the Atlantic diet with a reduction in mortality in countries such as Spain, the Czech Republic, Poland and the United Kingdom. The results, published in the European Journal of Preventive Cardiology , open up new possibilities for the development of nutritional guidelines adapted to this diet in Europe.

Pharmacology - Health - 19.12.2023
New oral treatment for COVID-19
New oral treatment for COVID-19
A clinical trial carried out by Hospital del Mar, Pompeu Fabra University, the Health Research Institute of Santiago de Compostela and the Pere Virgili Health Park investigated the efficacy and safety of a medicine for outpatients with COVID-19. The treatment acts on the replication mechanism of SARS-CoV-2, the virus responsible for the disease, and reduces the severity and duration of some of the symptoms.

Health - 14.12.2023
Altered Antiviral Pathways Identified in Autoimmune Disease
Altered Antiviral Pathways Identified in Autoimmune Disease
A team from the Universidad Autónoma de Madrid (UAM) and the Hospital Universitario de la Princesa has identified previously unknown alterations in a subtype of immune system cells in patients with Sjögren's syndrome. The finding, published in The EMBO Journal , could open up new avenues for the development of more specific and effective treatments against this chronic autoimmune disease.

Life Sciences - Health - 01.12.2023
Advances in the integration of metabolomics in an in vitro study of hepatotoxicity of new medical drugs
Advances in the integration of metabolomics in an in vitro study of hepatotoxicity of new medical drugs
A Universitat de València (UV) and IIS La Fe team, integrated in the Biomedical Research Centre in Network of Hepatic and Digestive Diseases (CIBERehd), has proven the potential of metabolomics for the study of hepatotoxicity of new medical drugs thanks to its relevance as a discovery tool of new biomarkers.

Health - Pharmacology - 29.11.2023
Use of pharmacogenetic biomarker in personalized therapy questioned
Use of pharmacogenetic biomarker in personalized therapy questioned
A team of pharmacogenetics experts from the Universidad Autónoma de Madrid (UAM) and the Hospital Universitario de La Princesa have questioned the clinical utility of a biomarker that has been assumed to hold promise for personalized drug treatments. The results, published in the journal Clinical Pharmacology and Therapeutics , highlight the importance of rigorous and continuous evaluation of pharmacogenetic biomarkers prior to their implementation in clinical practice.

Life Sciences - Health - 21.11.2023
IBiS develops new tools for spina bifida prevention research
IBiS develops new tools for spina bifida prevention research
IBiS research has discovered new phenotypes of neural tube defects in the loop-tail mouse model resistant to folic acid supplementation. These findings not only broaden our understanding of the disease, but provide valuable tools for future research into the prevention of conditions such as spina bifida.

Health - Social Sciences - 20.11.2023
The economic damage of a pandemic is inevitable, but targeted interventions can save more lives and lessen its social impact
According to an international scientific study in which the universities of Zaragoza and Carlos III de Madrid are participating 11/20/23 In order to minimise the impact of a pandemic on the economy, which would be more effective: a lockdown or letting individuals spontaneously reduce their risk of infection? Research recently published in the journal Nature Human Behaviour by Spanish scientists suggests that these two widely debated options lead to similar outcomes; that is, the economy will always be damaged, but at least a lockdown will save more lives.

Health - Pharmacology - 16.11.2023
A 17-kilogram suit for empathy training
A 17-kilogram suit for empathy training
How does a person with physical and sensory limitations feel? What are the restrictions for an elderly person who sees and hears poorly and whose joints are no longer what they used to be? Clinical researchers, especially those who deal with patients, have asked themselves that question and have tried to find the answer, and one of them has been the design of an aging and disability simulation suit.

Health - 02.11.2023
Beatriz Rodríguez-Labajos, member of the evaluation panel of the last call for ERC Starting Grants
Groundbreaking research reveals combining data supercharges mental health crisis prediction Groundbreaking research reveals combining data supercharges mental health crisis prediction In an extensive 8-year study published in Cell Reports Medicine conducted by Koa Health, researchers closely monitored 59,750 de-identified patient records, with a primary goal of predicting mental health crises occurring within a 28-day window.
1 2 3 4 5 10 Next »